» Articles » PMID: 21909878

Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells

Overview
Publisher Springer
Specialty Oncology
Date 2011 Sep 13
PMID 21909878
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclooxygenases (COX), prostaglandin E(2) (PGE(2)) and nitric oxide (NO) are believed to be some of the most important factors related to colon cancer growth and metastasis. In this study, we aimed to investigate the associations between COX-2, PGE(2) and NO in co-cultures of human colon cancer spheroids obtained from different tumor grades with normal human colonic epithelium and myofibroblast monolayers. L-arginine (2 mM), a substrate for nitric oxide synthases (NOS), decreased COX-2 and PGE(2) levels, while N( G )-nitro-L-arginine methyl ester (L-NAME) (2 mM), a NOS inhibitor, had no influence on COX-2 and PGE(2) levels but limited tumor cell motility. NS398 (75 μM), a selective COX-2 inhibitor, had no significant influence on NO level but decreased motility of tumor cells. COX-2, PGE(2) and NO levels depended on the tumor grade of the cells, being the highest in Duke's stage III colon carcinoma. Summing up, we showed that addition of L-arginine at doses which did not stimulate NO level caused a significant decrease in COX-2 and PGE(2) amounts in co-cultures of colon tumor spheroids with normal epithelial cells and myofibroblasts. Any imbalances in NO level caused by exogenous factors influence COX-2 and PGE(2) amounts depending on the kind of cells, their reciprocal interactions and the local microenvironmental conditions. The knowledge of these effects may be useful in limiting colon carcinoma progression and invasion.

Citing Articles

Influence of nitric oxide signaling mechanisms in cancer.

Ramirez-Patino R, Avalos-Navarro G, Figuera L, Varela-Hernandez J, Bautista-Herrera L, Munoz-Valle J Int J Immunopathol Pharmacol. 2022; 36:3946320221135454.

PMID: 36260949 PMC: 9585559. DOI: 10.1177/03946320221135454.


Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages.

Lee P, Liu C, Wang S, Chen K, Lin T, Liu P Toxins (Basel). 2021; 13(9).

PMID: 34564598 PMC: 8473227. DOI: 10.3390/toxins13090593.


Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update.

Jaen R, Prieto P, Casado M, Martin-Sanz P, Bosca L World J Gastroenterol. 2019; 24(48):5454-5461.

PMID: 30622375 PMC: 6319129. DOI: 10.3748/wjg.v24.i48.5454.


Silymarin and celecoxib ameliorate experimental varicocele-induced pathogenesis: evidences for oxidative stress and inflammation inhibition.

Mazhari S, Razi M, Sadrkhanlou R Int Urol Nephrol. 2018; 50(6):1039-1052.

PMID: 29623501 DOI: 10.1007/s11255-018-1862-5.


Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Salvemini D, Kim S, Mollace V Am J Physiol Regul Integr Comp Physiol. 2013; 304(7):R473-87.

PMID: 23389111 PMC: 4422342. DOI: 10.1152/ajpregu.00355.2012.

References
1.
Sun Q, Liu Q, Zheng Y, Cao X . Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation. Mol Immunol. 2008; 45(10):2929-36. DOI: 10.1016/j.molimm.2008.01.025. View

2.
Huang D, Shen K, Wei J, Liang T, Zheng S, Xie H . Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2. World J Gastroenterol. 2005; 11(2):204-7. PMC: 4205402. DOI: 10.3748/wjg.v11.i2.204. View

3.
Nishikawa M, Stapleton P, Freeman T, Gaughan J, Matsuda T, Daly J . NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. J Am Coll Surg. 2004; 199(3):428-35. DOI: 10.1016/j.jamcollsurg.2004.05.265. View

4.
Wendum D, Masliah J, Trugnan G, Flejou J . Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch. 2004; 445(4):327-33. DOI: 10.1007/s00428-004-1105-2. View

5.
Hsi L, Baek S, Eling T . Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells. Exp Cell Res. 2000; 256(2):563-70. DOI: 10.1006/excr.2000.4863. View